Invention Grant
- Patent Title: Nucleic acid construct that encodes chimeric rhodopsin
-
Application No.: US17731976Application Date: 2022-04-28
-
Publication No.: US11771741B2Publication Date: 2023-10-03
- Inventor: Toshihide Kurihara , Yusaku Katada , Kazuo Tsubota , Hideki Kandori
- Applicant: Restore Vision Inc.
- Applicant Address: JP Tokyo
- Assignee: Restore Vision Inc.
- Current Assignee: Restore Vision Inc.
- Current Assignee Address: JP Tokyo
- Agency: HALEY GUILIANO LLP
- Agent James F. Haley, Jr.; Xi Kang
- Priority: JP 19167553 2019.09.13
- Main IPC: A61K38/17
- IPC: A61K38/17 ; A61P27/02 ; C07K14/705 ; C07K19/00 ; C12N5/10 ; C12N15/62 ; C12N15/63 ; A61K38/16 ; A61K31/7088 ; C12N15/86

Abstract:
Provided are: a nucleic acid including a nucleic acid sequence encoding a chimeric protein including at least part of an ion-transporting receptor rhodopsin and at least part of a G protein-coupled receptor rhodopsin and a nucleic acid sequence encoding a signal sequence; and a nucleic acid including a nucleic acid sequence encoding a chimeric protein including at least part of an ion channeling receptor rhodopsin and at least part of a G protein-coupled receptor rhodopsin; and a nucleic acid construct including the nucleic acid sequences. The use of the nucleic acids or nucleic acid constructs prevents and suppresses the progress of retinal diseases, and enhances the visual cognitive behavioral function and visual function.
Public/Granted literature
- US20230248804A9 NUCLEIC ACID CONSTRUCT THAT ENCODES CHIMERIC RHODOPSIN Public/Granted day:2023-08-10
Information query
IPC分类: